Susquehanna International Group
LFSC

Susquehanna International Group’s F/m Emerald Life Sciences Innovation ETF LFSC Stock Holding History

Susquehanna International Group’s Portfolio LFSC Stock Details LFSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-253,148
Closed -$9.27M – 14385
2025
Q4 		$9.27M Buy
+253,148
New +$8.68M ﹤0.01% 3148

Other funds holding LFSC

EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
CCWP
Cedar Cove Wealth Partners Bloomington, Minnesota $213M AUM
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $8.94B AUM 20.84% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's LFSC Position: Q1 2026 in Review

Susquehanna International Group sold out of F/m Emerald Life Sciences Innovation ETF (LFSC) in Q1 2026, closing a stake of 253,148 shares — an estimated $9.27M sold.

Susquehanna International Group first reported a position in LFSC in Q4 2025 and held it in 1 quarter. The position peaked at $9.27M in Q4 2025. 7 funds tracked by Wall St. Rank hold LFSC as of Q1 2026.

  • Susquehanna International Group reported no remaining F/m Emerald Life Sciences Innovation ETF position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 253,148 F/m Emerald Life Sciences Innovation ETF shares in Q1 2026, an estimated $9.27M.
  • Susquehanna International Group first reported a position in F/m Emerald Life Sciences Innovation ETF in Q4 2025 and held it in 1 quarter.
  • Susquehanna International Group's F/m Emerald Life Sciences Innovation ETF position peaked at $9.27M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held F/m Emerald Life Sciences Innovation ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.